Clinical Trial

The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms

Study acronym: PIANO
Recruiting
View on ClinicalTrials.gov →
Summary
To determine safety and effectiveness of the p48 MW HPC and p64 MW HPC Flow Modulation Device in the treatment of wide-necked intracranial aneurysms.
Protocol Amendment History 3 changes
notable Trial sites expanded: 17 -> 21 locations 2026-06-26
notable Primary completion pushed: 2027-06 -> 2027-07 2026-04-14
minor Completion pushed: 2032-06 -> 2032-07 2026-04-14
Trial Details
NCT Number NCT07143019
Lead Sponsor phenox Inc.
Collaborators: Phenox GmbH
Conditions Hemorrhagic Stroke, Aneurysm, Intracranial, Saccular Aneurysm, Fusiform Aneurysm, Brain Aneurysm
Enrollment 214 participants
Start Date 2026-03-16
Primary Completion 2027-07 (estimated)
Study Completion 2032-07 (estimated)
Updated on ClinicalTrials.gov 2026-08-10